PM$500405$ - ορισμός. Τι είναι το PM$500405$
Diclib.com
Λεξικό ChatGPT
Εισάγετε μια λέξη ή φράση σε οποιαδήποτε γλώσσα 👆
Γλώσσα:

Μετάφραση και ανάλυση λέξεων από την τεχνητή νοημοσύνη ChatGPT

Σε αυτήν τη σελίδα μπορείτε να λάβετε μια λεπτομερή ανάλυση μιας λέξης ή μιας φράσης, η οποία δημιουργήθηκε χρησιμοποιώντας το ChatGPT, την καλύτερη τεχνολογία τεχνητής νοημοσύνης μέχρι σήμερα:

  • πώς χρησιμοποιείται η λέξη
  • συχνότητα χρήσης
  • χρησιμοποιείται πιο συχνά στον προφορικό ή γραπτό λόγο
  • επιλογές μετάφρασης λέξεων
  • παραδείγματα χρήσης (πολλές φράσεις με μετάφραση)
  • ετυμολογία

Τι (ποιος) είναι PM$500405$ - ορισμός

AN AUTOIMMUNE DISEASE
PM/Scl overlap syndrome; PM-Scl overlap syndrome; PM/Scl; PM-Scl; PM/SSc; PM-SSc

PM         
WIKIMEDIA DISAMBIGUATION PAGE
Pm; P.m.; PM (radio programme); PM (disambiguation); P.M. (disambiguation); PM (programme); Pm.; P.M.; P M; Pm (disambiguation)
Personal Message (Reference: BBS)
PM         
WIKIMEDIA DISAMBIGUATION PAGE
Pm; P.m.; PM (radio programme); PM (disambiguation); P.M. (disambiguation); PM (programme); Pm.; P.M.; P M; Pm (disambiguation)
Protected Mode (Reference: Intel, CPU)
Pm         
WIKIMEDIA DISAMBIGUATION PAGE
Pm; P.m.; PM (radio programme); PM (disambiguation); P.M. (disambiguation); PM (programme); Pm.; P.M.; P M; Pm (disambiguation)
¦ symbol the chemical element promethium.

Βικιπαίδεια

Scleromyositis

Scleromyositis, is an autoimmune disease (a disease in which the immune system attacks the body). People with scleromyositis have symptoms of both systemic scleroderma and either polymyositis or dermatomyositis, and is therefore considered an overlap syndrome. Although it is a rare disease, it is one of the more common overlap syndromes seen in scleroderma patients, together with MCTD and Antisynthetase syndrome. Autoantibodies often found in these patients are the anti-PM/Scl (anti-exosome) antibodies.

The symptoms that are seen most often are typical symptoms of the individual autoimmune diseases and include Raynaud's phenomenon, arthritis, myositis and scleroderma. Treatment of these patients is therefore strongly dependent on the exact symptoms with which a patient reports to a physician and is similar to treatment for the individual autoimmune disease, often involving either immunosuppressive or immunomodulating drugs.